Catalogue Number: CSB-MA000071M0M-CSB
Manufacturer: | Cusabio Biotech |
Preservative: | 0.03% ProClin™ 300 |
Ph: | 7.4 |
Physical state: | Liquid |
Type: | Monoclonal Primary Antibody - Unconjugated |
Shipping Condition: | Blue Ice |
Unit(s): | 100 ul, 50 ul |
Host name: | Mouse |
Clone: | 14C2F11 |
Isotype: | IgG1 |
Immunogen: | Recombinant Human GAPDH protein (3-335AA) |
Application: | ELISA, FC, IF, IP, WB, IHC |
Description: Glyceraldehyde 3-phosphate dehydrogenase (GAPDH or G3PDH) is an enzyme of 37kDa that is consisdered as a cellular enzyme involved in glycolysis. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a pleiotropic enzyme that is overexpressed in apoptosis and in several human chronic pathologies. Its role as a mediator for cell death has also been highlighted. At the molecular level, sequential steps lead to nuclear translocation of GAPDH during cell death as follows: first, a catalytic cysteine in GAPDH (C150 in rat GAPDH) is S-nitrosylated by nitric oxide (NO) that is generated from inducible nitric oxide synthase (iNOS) and/or neuronal NOS (nNOS); second, the modified GAPDH becomes capable of binding with Siah1, an E3 ubiquitin ligase, and stabilizes it; third, the GAPDH-Siah protein complex translocates to the nucleus, dependent on Siah1's nuclear localization signal, and degrades Siah1's substrates in the nucleus, which results in cytotoxicity. A recent report suggests that GAPDH may be genetically associated with late-onset of Alzheimer's disease.-deprenyl, which has originally been used as a monoamine oxidase inhibitor for Parkinson's disease, binds to GAPDH and displays neuroprotective actions.
Protein G purified
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Monoclonal